Drug retailers feel the heat as Amazon launches online pharmacy
Shares of drug retailers such as CVS Health Corp (NYSE: CVS) and Walgreens Boots Alliance Inc. (NASDAQ: WBA) fell in the mid-day trading Tuesday following the news.
avatar
Staff or Guest writer for The Dog of Wall Street.
2020-11-17 12:53

Amazon.com Inc. has launched an online pharmacy for selling prescription medicines across the U.S. Shares of drug retailers such as CVS Health Corp (NYSE: CVS) and Walgreens Boots Alliance Inc. (NASDAQ: WBA) fell in the mid-day trading Tuesday following the news.

Drug retailers feel the heat as Amazon launches online pharmacy

The new store, named Amazon Pharmacy, will allow customers to compare prices of the medicines on the app. They can choose between their copayment and a non-insurance option while checking out. Amazon will offer heavy discount to its prime members on the store.

The Seattle, Washington-based company has disrupted many industries along its tremendous growth journey. Amazon, which initially started its operations as an online bookseller, has been giving tough competition to companies in the retail and computing industries, and now the leading players in the pharmaceutical market will also face the heat after the latest announcement. The company has also faced criticism from labor groups and regulators in the past over its size and power.

The e-commerce giant’s new venture will now directly compete with Walgreens Boots, CVS Health, Walmart, Rite Aid, Kroger, and others. Online purchase of medicines has been relatively low as compared to physical store purchases. However, the pandemic may drive the online sales of drugs.

In case of Amazon, its prime members maybe more inclined to order drugs online through its newly opened store, as the company is offering up to 80 percent discount on generic and up to 40 percent discount on brand drugs when prime members decide to pay without insurance.

Amazon (NASDAQ: AMZN) shares slightly moved up in the mid-day trading Tuesday. If we look at the performance of the stock in the recent months, the stock has jumped more than 70 percent on year-to-date basis, about +31 percent over the past 6 months, and stayed nearly flat during the past 3 months.


Disclaimer: I have no positions in any of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article. All information should be independently verified and should not be relied upon for purposes of transacting securities or other investments. See terms for more info.

Rate this article

positive
negative
Published On
2020-11-17 12:53

avatar
About the Author
Staff or Guest writer for The Dog of Wall Street.


buy-coffee
You've read 1 article in the last year
..thank you for supporting us and for visiting our site. Unlike many other sites, The Dog of Wall Street is available for everyone to read. Our focus is to provide great content for free. Do you like what we are doing? Buy us a cup coffee. It is the fuel that keeps us going..

Is Tesla Back? Has TSLA Stock Finally Bottomed?
Tesla Stock Analysis: Robo Taxis to the Rescue?
By Mike Sakuraba | 2 weeks ago

2 Stocks to Buy During an April Pullback
Here are 2 stocks I’d buy during an April pullback.
By Mike Sakuraba | 2 weeks ago

TSM Stock: Is This The True Winner of the AI Race?
TSM’s stock has gained nearly 40% this year which is about half of NVIDIA has returned.
By Mike Sakuraba | 2 weeks ago

Best Proxy for Bitcoin: Coinbase or IBIT
In this article, we’ll compare the iShares Bitcoin Trust to Coinbase to see which is the best proxy for Bitcoin on the stock market.
By Mike Sakuraba | 3 weeks ago

2 Under the Radar AI Stocks to Buy
If you’re tired of reading about NVIDIA, consider these two AI stocks to add while the chip market cools off.
By Mike Sakuraba | 3 weeks ago

3 Bold Predictions for the Second Quarter
So here’s what I’m expecting for the second quarter and I’ll throw in a couple of bold predictions as well!
By Mike Sakuraba | 3 weeks ago

2 Stocks Cathie Wood Keeps Buying That You Should Too
In the world of retail investing, Cathie Wood and her Ark Invest fund are extremely polarizing.
By Mike Sakuraba | 1 month ago

2 Under the Radar Stocks to Buy Before Others
One of the keys to investing has always been to identify weaknesses in stocks before others. Buy it when everyone hates it and when everyone loves it you’ll reap the rewards. Sounds easy enough right?
By Mike Sakuraba | 1 month ago